Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Point of Care (POC) Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
POC analyzers are small-size, handheld or bench-top analyzers. These analyzers are small scale analyzers, often used in small laboratories and physician labs, where the workload and daily sample inflow is less. They often use disposable test cartridges and can provide faster results. One unit refers to one Point of Care (POC) analyzer.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Point of Care (POC) Analyzers under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Point of Care (POC) Analyzers and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Point of Care (POC) Analyzers under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Point of Care (POC) Analyzers Overview
Products under Development
Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
Table Figure 1: Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
Table Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
Point of Care (POC) Analyzers - Pipeline Products by Segment
Table Figure 2: Point of Care (POC) Analyzers - Pipeline Products by Segment
Table Point of Care (POC) Analyzers - Pipeline Products by Segment
Point of Care (POC) Analyzers - Pipeline Products by Territory
Table Figure 3: Point of Care (POC) Analyzers - Pipeline Products by Territory
Table Point of Care (POC) Analyzers - Pipeline Products by Territory
Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
Table Figure 4: Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
Table Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Table Figure 5: Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Table Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Point of Care (POC) Analyzers - Ongoing Clinical Trials
Table Figure 6: Point of Care (POC) Analyzers - Ongoing Clinical Trials
Table Point of Care (POC) Analyzers - Ongoing Clinical Trials
Point of Care (POC) Analyzers - Pipeline Products under Development by Companies
Point of Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
Table Point of Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
Point of Care (POC) Analyzers – Companies Pipeline Products by Stage of Development
Table Point of Care (POC) Analyzers – Companies Pipeline Products by Stage of Development
Point of Care (POC) Analyzers Companies and Product Overview
Access Bio Inc Company Overview
Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Electrochemiluminescent Based RNA Detection Platform - Product Status
Table Electrochemiluminescent Based RNA Detection Platform - Product Description
Point of Care (POC) Analyzers- Recent Developments
Nov 29, 2023: BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer
Nov 01, 2023: McKesson Corp. Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
Oct 18, 2023: Procisedx Expands Intellectual Property Portfolio With Purchase of Two US Therapeutic Drug Monitoring Patents
Oct 16, 2023: Alere Receives Additional 510(K) Clearance For Alere Afinion AS100 Analyzer
Oct 13, 2023: Alere Receives Additional 510(K) Clearance for Cholestech LDX Analyzer
Oct 12, 2023: Alere Receives 510(K) Clearance For Afinion 2 Analyzer
Aug 29, 2023: Co-Diagnostics Appoints Chief Regulatory Affairs Officer
Aug 28, 2023: AI Analysis of a Handheld Device Holds Potential to Speed Up Detection of Heart Failure
Aug 23, 2023: Medical Electronic Systems Receives 510(k) Clearance for SQA-iO Sperm Quality Analyzer
Aug 22, 2023: HealthtrackRx Expands National Footprint With Los Angeles Area PCR Laboratory
Aug 08, 2023: HealthTab Signs Reseller Agreement With Abbott to Support UK Expansion
Aug 01, 2023: AXIM Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
Jul 31, 2023: LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests
Jul 14, 2023: Introducing the Anbio AF-100S: A Small, Yet Powerful Handheld Analyzer for Rapid, Point-of-Care Testing
Jun 27, 2023: bioMErieux’s Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations
Jun 21, 2023: EDAN Showcases at FIME 2023 for Tapping New Potential in the Americas Market
May 26, 2023: The goal is to create a "biological computer", empower primary medical inspections and upgrades, and realize intelligent health data management
May 08, 2023: McKesson reports fiscal fourth-quarter and full-year results and raises long-term segment growth targets
May 05, 2023: Co-Diagnostics announces first quarter 2023 earnings release date and webcast
Mar 09, 2023: Co-diagnostics Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Webcast
Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022
Feb 22, 2023: Shenzhen Superbio Technology receives additional CLIA clearance for Superbio Immunofluorescence Analyzer EASY-11
Feb 02, 2023: Instrumentation Laboratory receives additional 510(k) clearance for GEM Premier ChemSTAT
Feb 02, 2023: SeLux Diagnostics receives CLIA approval for Selux AST System (Model AST Gen 1.0)
Jan 24, 2023: SeLux Diagnostics obtains 510(k) clearance for Selux AST System (Model AST Gen 1.0)
Jan 20, 2023: Selux Diagnostics secures FDA 510(k) clearance for AST testing NGP System
Jan 18, 2023: Cipla launches Cippoint – a point-of-care device for non communicable diseases, infectious diseases, and other health conditions
Jan 04, 2023: Shenzhen Superbio Technology receives CLIA clearance for Superbio Immunofluorescence Analyzer EASY-11
Dec 27, 2022: Shenzhen Superbio Technology receives 510(k) clearance for Superbio Immunofluorescence Analyzer EASY-11